SecBot SecBot

To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.

H.R. 4490 Rep. Brett Guthrie (R-KY-2) In committee
  1. Introduced Jul 6
  2. Committee Jul 6
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jul 6, 2023Next: House vote
1209d ago Jul 7, 2023: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Member trades
6trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This bill broadens the authority of pharmacies under the Controlled Substances Act to deliver certain controlled substances to health care practitioners for the purpose of administering the substance to a patient.

Full summary1 paragraphs

Under current law, pharmacies may deliver controlled substances in schedules III, IV, or V to a practitioner if it is for maintenance or detoxification treatment and is administered via injection or implantation, among other requirements. The bill applies this authority to any controlled substance in schedules III, IV, or V that is approved by the Food and Drug Administration to be administered by, or under the supervision of, a practitioner.

Library of Congress summary, Jul 6, 2023

Summary versions
  • Introduced in HouseJul 6, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.